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        Cytokines are secreted proteins that regulate 
multiple processes, including growth and dif-
ferentiation, cell survival, hematopoiesis, and 
immunological functions. Many cytokine ef-
fects are transduced through the JAK  –  STAT 
pathway. JAK proteins, when bound to cyto-
kine receptors, assemble in phosphorylated recep-
tor complexes that create docking sites for proteins 
such as the STATs, which contain Src homol-
ogy 2 domains. STATs are activated through 
phosphorylation by JAKs, and the activated 
STATs can dimerize and bind to DNA to acti-
vate transcription of target genes. Important 
STAT targets include the   suppressor of cytokine 
signaling   (  Socs  ) genes, which encode eight pro-
teins that inhibit a variety of signaling pathways 
(  1  ). SOCS proteins appear to inhibit cytokine 
signaling by targeting diff  erent components of 
the signaling complex either (a) by directly bind-
ing to activated, tyrosine phosphorylated cyto-
kine receptors or JAKs via their Src homology 2 
domains, or (b) by targeting receptor complexes 
for proteosomal degradation via the SOCS box 
(  1  ). Thus, stimulation of   Socs   transcription by 
STATs establishes a negative feedback loop that 
inhibits ongoing activation of cytokine signaling. 
SOCS proteins have been shown to play an im-
portant role in regulating cytokine activity at 
  several levels, including modulating cytokine 
production and by inhibiting downstream sig-
naling cascades (  1, 2  ). 
  Both in the hematopoietic system and in 
the liver, SOCS3 is a critical inhibitor of IL-6 
signal  ing mediated through the gp130 recep-
tor (  2  ). Mice defi  cient in the gp130 receptor 
in the liver do not produce STAT3 in response 
to IL-6 (  3  ), and Yang et al. showed that IL-6 
has a crucial role in the expression of   Socs3   dur-
ing infl  ammatory responses (  4  ). Inhibition of 
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  Suppressor of cytokine signaling 3 (SOCS3) down-regulates several signaling pathways in 
multiple cell types, and previous data suggest that SOCS3 may shut off cytokine activation 
at the early stages of liver regeneration (Campbell, J.S., L. Prichard, F. Schaper, J. Schmitz, 
A. Stephenson-Famy, M.E. Rosenfeld, G.M. Argast, P.C. Heinrich, and N. Fausto. 2001.
  J. Clin. Invest.   107:1285–1292). We developed   Socs3   hepatocyte-specifi  c knockout (  Socs3   
h-KO) mice to directly study the role of SOCS3 during liver regeneration after a two-thirds 
partial hepatectomy (PH).   Socs3   h-KO mice demonstrate marked enhancement of DNA 
replication and liver weight restoration after PH in comparison with littermate controls. 
Without SOCS3, signal transducer and activator of transcription 3 (STAT3) phosphorylation 
is prolonged, and activation of the mitogenic extracellular signal-regulated kinase 1/2 
(ERK1/2) is enhanced after PH. In vitro, we show that SOCS3 defi  ciency enhances hepato-
cyte proliferation in association with enhanced STAT3 and ERK activation after epidermal 
growth factor or interleukin 6 stimulation. Microarray analyses show that SOCS3 modu-
lates a distinct set of genes, which fall into diverse physiological categories, after PH. 
Using a model of chemical-induced carcinogenesis, we found that   Socs3   h-KO mice develop 
hepatocellular carcinoma at an accelerated rate. By acting on cytokines and multiple 
proliferative pathways, SOCS3 modulates both physiological and neoplastic proliferative 
processes in the liver and may act as a tumor suppressor. 92 ROLE OF SOCS3 IN LIVER REGENERATION AND HCC | Riehle et al.
    RESULTS   
  Liver regeneration is enhanced in   Socs3   h-KO mice 
    Socs3   is robustly induced during the fi  rst few hours after PH 
(  9  ), suggesting that SOCS3 might act as a negative regulator 
of liver regeneration. To determine whether   Socs3   defi  ciency 
altered regeneration, we generated   Socs3   h-KO mice (  2  ). In the 
absence of an operative or chemical stimulus,   Socs3   h-KO liv-
ers were identical to those of control littermates in weight, 
histology, and proliferative and apoptotic indices (unpublished 
data). To determine whether the lack of SOCS3 would have 
an eff  ect on DNA replication after PH, we evaluated the pro-
liferative response to PH in   Socs3   h-KO mice compared with 
that of littermates with intact   Socs3  . Surprisingly,   Socs3   h-KO 
mice display marked enhancement of hepatocyte DNA repli-
cation, as shown by increased BrdU incorporation (  Fig. 1 A  ).   
Nuclear hepatocyte BrdU labeling in   Socs3   h-KO mice is sig-
nifi  cantly higher than in control littermates from 32 to 48 h 
after PH, and is 90  –  160% higher at the peak of DNA replica-
tion between 36 and 40 h after PH. Additionally, the number 
of hepatocyte mitoses is 85 and 89% higher in   Socs3   h-KO 
mice than that of controls at 48 and 72 h, respectively (  Fig. 1 B  ). 
As a consequence of the increased hepatocyte replication 
in   Socs3   h-KO mice, these animals restore their liver weights 
after PH 2 d earlier than do controls (  Fig. 1 C  ). To further 
demonstrate negative regulation by SOCS3 of the progression 
of hepatocytes through the cell cycle in the regenerating liver, 
we performed immunoblotting for the cell-cycle proteins cy-
clin A and p107, which are known to be up-regulated during 
liver regeneration (  10  ). Lysates harvested between 24 and 48 h 
after PH showed that   Socs3   h-KO mice had both earlier and 
increased expression of these proteins during liver regenera-
tion, particularly p107, which is strongly expressed in   Socs3   
h-KO mice from 32 to 48 h after PH (  Fig. 1 D  ). 
  Though previous work has demonstrated that 90  –  95% of 
hepatocyte genomic   Socs3   is excised in   Socs3   h-KO mice (  2  ), 
we wanted to be certain that the strong physiological stimulus 
of PH (  9  ) would not lead to signifi  cant expression from resid-
ual copies of the gene and that expression by nonparenchymal 
cells (NPCs) was very low. We thus performed Northern 
blotting for   Socs3   on RNA isolated from   Socs3   h-KO and 
control littermates at various times after PH. We found virtu-
ally no induction of   Socs3   after PH in the KO mice at any of 
the times examined (  Fig. 1 E  ) and, similarly, did not observe a 
compensatory up-regulation of   Socs1   (  Fig. 1 F  ). In summary, 
the data presented in this section clearly demonstrate that 
SOCS3 defi  ciency increases hepatocyte replication and accel-
erates liver regeneration after PH. 
  Activation of STAT3 and extracellular signal-regulated 
kinase (ERK) signaling pathways in   Socs3   h-KO mice 
after PH 
  After PH, IL-6 is released by Kupff  er cells (  11  ) and subse-
quently binds its specifi  c receptor on the surface of hepato-
cytes. Receptor binding activates JAK to phosphorylate and 
activate STAT3, which then dimerizes and translocates to the 
nucleus. As we have previously shown that   Socs3   expression 
this pathway involves the binding of SOCS3 to phosphoty-
rosine 759 of the activated gp130 receptor (  5  ). IL-6 is one of 
the main mediators of the acute-phase response, which is 
induced by infl  ammatory stimuli in the liver. By regulating 
the activity of the IL-6  –  gp130 pathway, SOCS3 could have 
a major effect on the acute-phase response to liver injury 
or infl  ammation. 
  One of the most interesting fi  ndings regarding the mech-
anisms that initiate liver regeneration after two-thirds partial 
hepatectomy (PH) is the demonstration that several compo-
nents of the innate immune system may be involved in the 
initiation process. These components, which include cyto-
kines such as IL-6, proteins of the complement system, and 
lymphotoxins, are particularly active during the fi  rst 12  –  18 h 
after PH, a time period during which hepatocytes transition 
from a quiescent state into the cell cycle. Through work with 
animal models, we and others have shown that IL-6 is a com-
ponent of a cytokine pathway activated very shortly after PH 
that involves signaling through TNFR1 and the activation 
of the transcription factors NF-    B and STAT3 (  6  –  8  ). It ap-
pears that the components of this pathway are involved in 
both cell survival and hepatocyte replication (  6, 8  ). Data from 
our laboratory showed that   Socs3   is highly expressed between 
2 and 8 h after PH, which partially overlaps with the time 
frame of STAT3 expression, and that   Socs3   expression in the 
regenerating liver is IL-6 dependent (  9  ). We concluded from 
these experiments that in the initial stages of liver regenera-
tion, SOCS3 might shut off   the early cytokine response, per-
haps to protect liver cells against the cytotoxic eff  ects of 
prolonged cytokine expression. However we did not have 
direct evidence either to support this hypothesis or to deter-
mine whether SOCS3 might have other functions in the 
regenerating liver. Because   Socs3   KO mice die during em-
bryogenesis, we developed mice in which   Socs3   was specifi  -
cally deleted in hepatocytes (  Socs3  fl / fl     ,   Alb-Cre  +    ; termed   Socs3   
hepatocyte-specifi  c knockout [h-KO] mice) and used these 
animals to directly investigate the role of SOCS3 during 
liver regeneration. 
  Our main expectation was that   Socs3   h-KO mice would 
show a prolonged acute-phase response, and that excessive 
cytokine signaling would lead to toxicity and a decrease in 
cell proliferation after PH. Contrary to these expectations, 
we demonstrate that in the absence of SOCS3, (a) hepato-
cyte DNA replication and progression through the cell cycle 
are markedly enhanced after PH, leading to an acceleration 
of liver regeneration; (b) hepatocytes isolated from   Socs3   
h-KO mice have an increased replication capacity; and (c) 
  Socs3  -defi  cient mice develop hepatocellular carcinoma (HCC) 
at an accelerated rate. These data suggest that, in addition to 
its role in the control of cytokine expression in the regener-
ating liver, SOCS3 coordinates the responses of innate im-
mune system components with that of proliferative pathways. 
Coordination between these systems may be required for the 
precise regulation and synchronization of hepatocyte pro-
liferation during liver regeneration and for the prevention 
of tumorigenesis in such a highly prolifera  tive environment. JEM VOL. 205, January 21, 2008 
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PH is prolonged in   Socs3   h-KO mice compared with litter-
mates (  Fig. 2, C and D  ). We measured IL-6 levels at 18 and 
24 h after PH to confi  rm that this cytokine is not expressed 
later in   Socs3   h-KO mice, thus contributing to prolonged ex-
pression of these genes, and did not observe elevated levels of 
IL-6 in either   Socs3   h-KO or control littermates at these times 
(unpublished data). We also determined whether either STAT1 
or STAT5 are abnormally activated in the absence of SOCS3 
by immunoblotting for phospho-STAT1 and -STAT5 on 
liver lysates prepared from   Socs3   h-KO mice and littermates 
from 0 to 12 h after PH. We did not observe any activation 
of either STAT1 or STAT5 at any of the times examined 
(unpublished data). 
  TNF and IL-6 participate in both the initiation of liver 
regeneration and the induction of the acute-phase response, 
which are very diff  erent biological processes (  12  ). We show 
that in SOCS3-defi  cient mice, both cell proliferation and 
the expression of some acute-phase response genes are en-
hanced, suggesting that both processes may be negatively 
regulated by SOCS3. Phosphorylation of the mitogen-activated 
after PH is largely dependent on the IL-6  –  STAT3 signaling 
pathway (  9  ), we examined the activation of this pathway 
during liver regeneration in   Socs3   h-KO mice. Serum IL-6 
levels were determined by ELISA from 30 min to 12 h after 
PH and do not signifi  cantly diff  er between   Socs3   h-KO and 
control littermates (  Fig. 2 A  ).   This result is not unexpected, 
because the production of IL-6 by NPCs would not be al-
tered by SOCS3 defi  ciency in hepatocytes. However, there 
is a marked diff  erence in the phosphorylation of STAT3 be-
tween   Socs3   h-KO and control littermates. STAT3 phos-
phorylation is still present 12 h after PH in   Socs3   h-KO mice, 
whereas it is no longer detectable in control littermates, as 
shown by immunoblotting (  Fig. 2 B  ). These data confi  rm the 
observation that SOCS3 acts in a negative feedback loop to 
arrest STAT3 activation in hepatocytes during liver regenera-
tion. To confi  rm that this prolonged activation of STAT3 
would lead to diff  erences in gene expression, we examined 
the induction   Cd14   and   Saa2  , which are two acute-phase 
  response genes and known STAT3 targets in the liver. North-
ern blot analysis shows that the expression of these genes after 
    Figure 1.         Liver regeneration is enhanced in   Socs3   h-KO mice.   (A) Staining for BrdU indicates increased DNA synthesis in   Socs3   h-KO  mice. 
(B) Increased mitotic fi  gures in hepatocytes lacking   Socs3.   (C) More rapid return to preoperative liver weight in the absence of   Socs3.   (D)  Increased 
  expression of cyclin A and p107 in   Socs3   h-KO mice after PH, demonstrated by immunoblotting.     -Actin and     -tubulin are shown as loading controls. 
(E) Confi  rmation of lack of   Socs3   induction after PH in   Socs3   h-KO mice by Northern blotting, with cyclophilin as a loading control. (F) Northern blotting 
demonstrates no compensatory up-regulation of   Socs1   in the absence of   Socs3  . Data shown are representative of three to six mice per genotype per time 
point and are presented as mean   ±   SEM. *, P   <   0.05.     94 ROLE OF SOCS3 IN LIVER REGENERATION AND HCC | Riehle et al.
hepatocytes lacking SOCS3 is approximately double of that 
of hepatocytes with intact SOCS3 (  Fig. 3 A  ).   These data in-
dicate that SOCS3 defi  ciency appears to result in autocrine 
mechanisms that lead to enhanced hepatocyte replication. 
The diff  erence between the proliferative response of hepato-
cytes from   Socs3   h-KO mice and their littermates in culture 
was further accentuated by exposure of the cells to EGF (  Fig. 
3 B  ). After 62 and 86 h in culture, EGF-stimulated hepato-
cytes from SOCS3-defi  cient mice incorporate [  3  H]thymidine 
at a rate that is almost fourfold higher than the hepatocytes 
from control littermates. Similar to our fi  ndings in the regen-
erating liver in vivo, SOCS3-defi  cient hepatocytes in culture 
displayed increased activation of STAT3 and ERK1/2 in 
  response to EGF (  Fig. 3, C and D  ). Thus, the defi  ciency in 
SOCS3 not only increases the intrinsic replicative capacity of 
hepatocytes but also makes them more responsive to the pro-
liferative eff  ects of growth factors such as EGF. 
  JAK inhibition by AG490 and MAPK/ERK kinase (MEK) 
inhibition by U0126 inhibit hepatocyte proliferation in vitro 
  The data presented suggest that enhanced signaling through 
STAT3 and ERK1/2 may be responsible for the heightened 
proliferative state of SOCS3-defi  cient cells. We thus used small 
molecule inhibitors of the upstream kinases JAK (upstream 
of STAT3) and MEK (upstream of ERK1/2) to determine 
  protein kinases (MAPKs) ERK1/2 has been shown to be a 
key event in the regenerative response to PH and is believed 
to occur via activation of the epidermal growth factor recep-
tor (EGFR) by a variety of ligands (  13  ). We found that the 
increased   proliferative activity in   Socs3   h-KO mice after PH 
is associated with a marked increase in phospho-ERK1/2, 
particularly at 18 and 24 h after PH (  Fig. 2 E  ). Thus, SOCS3 
defi  ciency after PH accelerates liver regeneration, prolongs 
STAT3 activation and the acute-phase response, and enhance 
ERK1/2 activation. 
    Socs3  -defi  cient hepatocytes exhibit enhanced proliferation 
in vitro, associated with increased phosphorylation of 
STAT3 and ERK1/2 
  After demonstrating the marked enhancement of both cyto-
kine signaling and hepatocyte proliferation during liver re-
generation, an in vivo growth process that restores liver mass 
after removal of two thirds of the liver, we asked whether 
primary hepatocytes isolated from   Socs3   h-KO mice also dis-
play enhanced proliferative activity in culture. For these 
  experiments, we perfused the livers of   Socs3   h-KO and con-
trol mice with collagenase, Percoll-purifi  ed the hepatocytes, 
plated them in media containing 5% serum for attachment, 
and maintained the cells in the absence of serum or growth 
factors. We found that the incorporation of [  3  H]thymidine in 
    Figure 2.         Activation of STAT3 and ERK1/2 are enhanced in   Socs3   h-KO mice.   (A) Serum IL-6 levels after PH are unchanged in   Socs3   h-KO  mice 
(ELISA). (B) Lack of SOCS3 in hepatocytes leads to prolonged phosphorylation of STAT3 (Y705) after PH, demonstrated by immunoblotting. (C) Northern 
blot analysis indicates prolonged expression of   Cd14 Socs3   h-KO mice. (D)   Saa2   expression is also prolonged in   Socs3   h-KO mice. (E)   Socs3   defi  ciency 
leads to enhanced phosphorylation of ERK1/2 after PH, demonstrated by immunoblotting. All demonstrated data are representative of three to six mice 
per genotype per time point and are presented as mean   ±   SEM. *, P   <   0.05.     JEM VOL. 205, January 21, 2008 
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    Socs3  -defi  cient hepatocytes exhibit enhanced activation 
of multiple IL-6  –  dependent signaling pathways 
  The observations that both STAT3 and ERK1/2 activation 
are prolonged in vivo after PH in   Socs3  -defi  cient livers and in 
vitro after EGF stimulation of   Socs3   defi  cient hepatocytes 
suggested that SOCS3 may also inhibit signaling pathways 
downstream of IL-6. To determine whether IL-6 stimulation 
of   Socs3  -defi  cient hepatocytes in culture would alter the re-
sponse of downstream pathways, hepatocytes isolated from 
  Socs3   h-KO mice and control littermates were exposed to 
IL-6. Protein lysates were prepared at the indicated times, and 
phosphorylation of STAT3, ERK1/2, Akt, and S6 protein was 
analyzed by phosphoimmunoblotting. IL-6  –  induced STAT3 
phosphorylation is prolonged in   Socs3   h-KO hepatocytes 
whether we could decrease the proliferation of   Socs3   KO 
cells to the level of control hepatocytes. As expected, AG490, 
a JAK inhibitor, inhibits STAT3 phosphorylation in response 
to IL-6 in cultured hepatocytes, whereas the vehicle control 
(DMSO) has no eff  ect on IL-6  –  stimulated STAT3 phosphoryl-
ation (  Fig. 4 A  ).   When added to culture medium 1 h before the 
addition of EGF, AG490 also inhibits hepatocyte prolifera-
tion, as measured by [  3  H]thymidine incorporation (  Fig. 4 B  ). 
Addition of U0126, a selective MEK inhibitor, inhibits both 
ERK1/2 activation (  Fig. 4 C  ) and hepatocyte proliferation 
(  Fig. 4 D  ) in response to EGF. These results indicate that 
SOCS3 can modulate hepatocyte replication in vitro through 
eff  ects on both the STAT3 and MAPK signaling pathways, 
similar to our in vivo observations. 
    Figure 3.         SOCS3 down-regulates hepatocyte proliferation and growth factor signaling in vitro.   (A)  [ 3  H]Thymidine incorporation by primary 
  hepatocytes in the absence of growth factors 36 h after isolation and initiation of cell culture. (B) Hepatocyte proliferation in response to 20 ng/ml EGF. 
(C) Pi-STAT3  Y705   is enhanced in response to EGF in   Socs3 -defi  cient hepatocytes. (D) Similar enhancement of Pi-ERK1/2 in response to EGF in   Socs3   KO 
hepatocytes. All data are representative of at least three separate experiments, with four to six replicates in each   3  H experiment, and are presented as 
mean   ±   SEM. *, P   <   0.05.     
    Figure 4.         Inhibition of JAK or MEK in culture inhibits hepatocyte proliferation.   (A) AG490 inhibits tyrosine phosphorylation of STAT3. (B) AG490 
inhibits hepatocyte proliferation ([  3  H]thymidine assay). (C) U0126 inhibits ERK activation in response to EGF. (D) U0126 inhibits hepatocyte proliferation 
([  3  H]thymidine assay). Data are representative of three independent experiments and are presented as mean   ±   SEM. *, P   <   0.05.   96 ROLE OF SOCS3 IN LIVER REGENERATION AND HCC | Riehle et al.
the lack of SOCS3 has broad eff  ects on gene expression dur-
ing liver regeneration, we performed complementary DNA 
(cDNA) microarray analysis on RNA prepared from   Socs3   
h-KO mice and control littermates 18 h after PH. Three pooled 
samples per genotype were applied to Aff  ymetrix oligonucle-
otide arrays, and data were analyzed as described in Supple-
mental materials and methods (available at http://www.jem
.org/cgi/content/full/jem.20070820/DC1). The heatmap 
shown in   Fig. 6 A   represents a global view of diff  erential gene 
expression patterns in   Socs3   h-KO mice versus control litter-
mates at 18 h after PH.   The map demonstrates uniformity of 
expression among the pools for each genotype and reveals 
striking diff  erences in gene expression profi  les between   Socs3   
h-KO mice and control littermates. The Aff  ymetrix data were 
subjected to National Institutes of Health (NIH) database for 
annotation, visualization, and integrated discovery (DAVID) 
analysis and Kyoto Encyclopedia of Genes and Genomes an-
notation. NIH DAVID analysis of diff  erentially regulated 
genes revealed that several pathways thought to be important in 
liver regeneration are enhanced in   Socs3   h-KO mice (  Fig. 6 B  ). 
In addition to the JAK  –  STAT and MAPK signaling pathways, 
which we had already shown to be enhanced in the absence 
of SOCS3, we found that Toll-like receptor (TLR) signaling 
and cytokine  –  cytokine receptor interaction, focal adhesion, 
and Wnt signaling pathways are similarly up-regulated. These 
pathways have been shown by multiple investigators to be 
critical to normal regeneration (  13, 15, 16  ), and in some cases 
may be involved in the development of HCC (  8, 17, 18  ). Our 
microarray data support the view that the enhancement of 
multiple intracellular signaling pathways in   Socs3   h-KO mice 
allows them to regenerate more effi   ciently than control litter-
mates. Interestingly, DAVID analysis revealed that bile acid 
synthesis and fatty acid metabolism were down-regulated in 
  Socs3   h-KO mice in comparison with control littermates, sug-
gesting that SOCS3 may enhance rather than inhibit these 
functions. Recent data suggest that these pathways are them-
selves necessary for optimal liver regeneration (  19, 20  ). Our 
results do not necessarily contradict these studies, as the multi-
ple changes created by SOCS3 defi  ciency may alter the liver 
metabolic requirements during regeneration. 
  To validate our microarray gene expression data, we per-
formed real-time RT-PCR on several genes that had been 
shown to be up-regulated in   Socs3   h-KO mice. Work by 
several investigators has shown that c-jun, a subunit of the 
transcription factor activator protein 1, is critical to the pro-
liferative response after PH (  21  ), and data from our laboratory 
suggest that AP-1 activity may be necessary for induction of 
heparin-binding EGF (unpublished data; Mitchell, C., per-
sonal communication), a member of the EGF family that par-
ticipates in the linkage between cytokine activity and cell-cycle 
progression during regeneration (  22  ). In the present study, 
we found that the expression of   c-jun   messenger RNA is ap-
proximately twofold higher in   Socs3   h-KO mice compared 
with littermates (  Fig. 6 C  ). 
  We also observed increased expression of haptoglobin, an 
acute-phase response protein, further supporting our observation 
compared with controls (  Fig. 5 A  ).   ERK1/2 activation is bi-
phasic, peaking at 30 and 120 min after IL-6 treatment (  Fig. 
5 B  ), and although the initial activation of ERK1/2 appears 
to be similar in hepatocytes from   Socs3   h-KO mice and lit-
termates,   Socs3   KO hepatocytes demonstrate prolonged acti-
vation of ERK1/2 compared with control cells. 
  The protein kinase target of rapamycin (TOR) complexes 
1/2, which regulate mammalian TOR (mTOR), are in-
volved in multiple cellular processes, such as protein transla-
tion, nutrient sensing, and cell growth (  14  ). To determine 
whether   Socs3   could regulate IL-6  –  stimulated mTOR activ-
ity, we examined the levels of phospho-S6 ribosomal pro-
tein, a downstream target of mTOR. We observed enhanced 
and prolonged phosphorylation of S6 protein in   Socs3   KO 
cells (  Fig. 5 C  ), indicating that S6 kinase is activated to a 
greater extent, and thus, the mTOR pathway may also be 
enhanced. In contrast, Akt phosphorylation and activation, as 
determined by phospho-S473  –  Akt and a phospho-Akt sub-
strate antibody, is similar in   Socs3   KO and control hepato-
cytes after IL-6 treatment (  Fig. 5 D  ). These results confi  rm 
that IL-6 stimulates multiple signaling pathways, such as those 
mediated by STAT3, ERK1/2, Akt, and S6 kinase in pri-
mary hepatocytes, and that SOCS3 defi  ciency results in pro-
longed and enhanced activation of some of these pathways. 
  The absence of   Socs3   results in profound changes in gene 
expression after PH 
  Given the signifi  cant enhancement of liver regeneration ob-
served in   Socs3   h-KO mice and our fi  ndings in vitro, we hy-
pothesized that diverse cellular pathways contribute to the 
proliferative advantage of these cells. To determine whether 
    Figure 5.         Activation of STAT3, ERK1/2, and Akt are prolonged 
in   Socs3   KO hepatocytes after IL-6 treatment.   (A)  Pi-STAT3 Y705   is 
prolonged in response to IL-6 in   Socs3   KO hepatocytes. (B) Activation of 
ERK1/2 is enhanced in response to IL-6 in   Socs3   KO hepatocytes. (C) 
Prolonged activation of Pi-S6   S240/244   ribosomal protein in   Socs3   KO  versus 
littermate hepatocytes.     -Actin is shown as a loading control. (D) No 
difference in activation of Akt in   Socs3   versus control hepatocytes. Data are 
representative of three to fi  ve independent experiments.     JEM VOL. 205, January 21, 2008 
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of three angiogenic factors in the livers of   Socs3   h-KO mice 
suggests that initiation of liver architecture remodeling seen 
after PH may occur earlier in these mice. Collectively, our 
real-time RT-PCR results both validate our microarray data 
and provide additional insight into potential mechanisms be-
hind the enhancement in liver regeneration seen in   Socs3   
h-KO mice. 
  Promoter analysis after PH in   Socs3   h-KO mice 
  We were also interested in identifying the potential regula-
tory networks that might account for the changes in messen-
ger RNA expression identifi  ed by the microarray and, thus, 
used transcriptional regulatory network analysis (TRNA) us-
ing the promoter analysis and interaction network tool 
(PAINT), as described in Materials and methods (  27  ). TRNA 
of extended STAT3 activation in   Socs3   h-KO mice (  Fig. 2  ). 
I    B     is rapidly resynthesized after it is phosphorylated and de-
graded, which results in the release and activation of NF-    B 
(  23, 24  ). We observed increased expression of   I    b       in   Socs3   
h-KO mice, suggesting that NF-    B was active at 18 h after PH 
in these animals. Increased expression of   I    b       is also consistent 
with the enrichment of genes in the TLR pathway (  Fig. 6 B  ). 
  Hypoxia-inducible factor 1     (  Hif1      ) is induced under hyp-
oxic conditions and transcribes factors that are important to 
angiogenesis, and has been reported to increase after PH (  25  ). 
  Hif1       expression was signifi  cantly increased in   Socs3   h-KO mice 
compared with littermates after PH. Both platelet-derived 
growth factor C (  Pdgfc  ) and PDGF receptor      (  Pdgfr      ) tran-
scribe potent angiogenic factors (  26  ), and were signifi  cantly 
up-regulated in   Socs3   h-KO mice. The increased expression 
    Figure 6.         Oligonucleotide microarrays demonstrate broad and diverse effects of SOCS3 on gene expression after PH.   (A) Heatmap demon-
strating a global picture of differential gene expression in   Socs3   h-KO mice versus control littermates at 18 h after PH. (B) NIH DAVID analysis of a 
  differentially regulated gene list reveals that multiple pathways are differentially regulated during regeneration in   Socs3   h-KO mice. (C) Confi  rmed up-
regulation of   c-jun ,  Haptoglobin ,  Hif1 a  ,  I k B a  ,  Pdgf-c  , and   Pdgfr a    in   Socs3   h-KO mice versus control littermates at 18 h after PH, demonstrated by 
real-time RT-PCR. Data are presented as fold change using the values from nonoperated mice as the denominator and are presented as mean   ±   SEM. 
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up-regulated in these cancers (  17  ). Because we have shown 
that SOCS3 is a critical negative regulator of these pathways 
during the physiological regenerative response to PH, we 
wondered whether a lack of SOCS3 would promote neoplas-
tic proliferative processes as well. To test this hypothesis, we 
used a model of DEN-induced hepatocarcinogenesis, in 
which   Socs3   h-KO mice and control littermates were injected 
with a single dose of DEN at 12  –  14 d of life. The mice re-
ceived no other treatment and were killed between 3 and 12 mo 
of age. Foci of altered hepatocytes were observed by 6 mo of 
age in both   Socs3   h-KO mice and littermates but were larger 
in size in   Socs3   h-KO mice (1.2 vs. 0.5% of the area).   Socs3   
h-KO mice developed HCC signifi  cantly earlier and in greater 
numbers than did littermate controls (  Table II  ).   By 9 mo, four 
out of six SOCS3-defi   cient mice had developed tumors, 
whereas none were detected in the control littermates; by 12 
mo, all   Socs3   h-KO mice had developed HCC. The tumors 
were typical trabecular-type HCCs with a moderate degree of 
diff  erentiation (unpublished data). Using immunoblot analy-
sis, we observed increased levels of activated, phosphorylated 
ERK1/2 in the tumor tissue from 9-mo   Socs3   h-KO mice 
compared with adjacent tissue, as well as from liver tissue 
was performed for genes found to be up-regulated   >  1.5-fold 
in   Socs3   h-KO mice to identify transcription factor binding 
sites or transcriptional regulatory elements (TREs) in the 5     
fl  anking regions. The most enriched TREs in the gene set are 
listed by consensus sequence, along with their associated tran-
scription factors, categorized, and ranked by frequency of 
presence in   Table I  .   Most notably, TREs for several members 
of the NF-    B promoter family (p65, NF-    B, and c-Rel) are 
among the most overrepresented, consistent with the enrich-
ment of cytokine signaling and TLR pathways determined by 
DAVID analysis (  28  ). Additionally, the presence of the TRE 
for Elk-1, a downstream target of the MAPK pathway, sup-
ports our fi  ndings of extended and increased ERK1/2 activa-
tion in   Socs3   h-KO mice (  Fig. 2 E  ). Collectively, these results 
corroborate our in vivo and in vitro data demonstrating the 
increased proliferative capacity in   Socs3   h-KO mice after PH, 
in the context of enhanced signaling via multiple pathways. 
  Accelerated development of   N  -nitrosodiethylamine (DEN)  –
  induced HCC in   Socs3   h-KO mice 
  Recent work on human HCCs demonstrated that the JAK  –
  STAT and/or Ras-Raf  –  MAPK pathways are virtually always 
    Table I.        TREs enriched in   Socs3   h-KO mice 18 h after PH 
Candidate binding factor for TRE TRE consensus sequence Counts p-value
NF-    B superfamily
     c-Rel SGGRNTTTCC 87 0.05
     NF-    B NGGGGAMTTTCCNN 20 0.25
     NF-    B GGGAMTTYCC 15 0.02
     NF-    B (p65) GGGRATTTCC 12 0.01
Cell growth and proliferation
     Elk-1 NAAACMGGAAGTNCVH 71 0.02
     c-Jun/CRE-BP1 TGACGTYA 42 0.28
     CREB TGACGTMA 39 0.09
     Evi-1 WGAYAAGATAGATAA 25 0.19
     E2F TTTSGCGC 20 0.04
     ATF-2/CRE-BP1 VGTGACGTMACN 14 0.28
     CREB NSTGACGTAANN 11 0.07
     Egr-1 WTGCGTGGGCGK 1 0.39
     Egr-3 NTGCGTGGGCGK 1 0.28
Differentiation and hepatocyte specifi  city
     USF GYCACGTGNC 49 0.09
     Pax-6 NNNNTTCACGCWTGANTKNNN 34 0.28
     USF NCACGTGN 31 0.28
     CP2 GCHCDAMCCAG 23 0.17
     Oct-1 CWNAWTKWSATRYN 22 0.28
     HNF-4/COUP-TF TGAMCTTTGMMCYT 12 0.05
     Oct-1 MKVATTTGCATATT 7 0.41
     MEF-2 NNTGTTACTAAAAATAGAAMNN 2 0.21
Enriched TREs (biologically relevant transcription factor binding sites) were identifi  ed by comparing promoter regions of genes up-regulated   >  1.5-fold in   Socs3   h-KO  mice 
to all   M. musculus   promoter regions in the PAINT database. To identify TREs overrepresented, 5 kb of upstream sequence of each gene from the list of signifi  cantly up-
regulated genes was analyzed by PAINT. TRE consensus sequence is the consensus binding site for the indicated binding factor (known transcription factor), provided as the 
International Union of Pure and Applied Chemistry 15-letter code. Multiple listings of candidate binding factors are based on differences in consensus binding sites. Count 
refers to the total number of times the TRE was found in the gene set. p-values were calculated as described in Materials and methods.JEM VOL. 205, January 21, 2008 
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cell factor participate in the replicative response of hepato-
cytes after PH (  32, 34  ). Although it may appear that the cyto-
kine and growth factor pathways in the regenerating liver may 
have distinct functions, these networks may overlap in some 
cases. For instance, it has been demonstrated that STAT3 ac-
tivates multiple genes and contributes to hepatocyte replication 
during liver regeneration (  16  ). Moreover, IL-6 has multiple 
functions, including cell survival, cell proliferation, and the 
acute-phase response to infl  ammation (  35  –  37  ), and the role of 
IL-6 in the regenerating liver remains a controversial issue. 
Thus, it is unclear how cytokines and growth factors may 
  interact to produce the precisely orchestrated liver growth re-
sponse that occurs after PH. 
  SOCS proteins were originally described as negative regu-
lators of cytokine signaling. More recent studies using specifi  -
cally targeted mouse models reveal that, in the hematopoietic 
system, SOCS1 and SOCS3 inhibit myeloid signaling path-
ways and may infl  uence conditions such as infl  ammation, auto-
immunity, and malignancy (  17, 38  –  41  ). In the liver, SOCS3 
regulates the activity of the cytokine pathway stimulated by 
from control littermates (unpublished data), suggesting that 
signaling pathways that control proliferation may be activated 
in   Socs3  -defi  cient tumors. 
  Previous work suggested that SOCS3 may decrease tu-
mor formation in the liver by blocking apoptosis (  29  ), so we 
examined the extent of apoptosis induced by DEN in our 
mice using a caspase 3 activity assay (  30  ). We found no diff  er-
ences among caspase activities of   Socs3   h-KO mice and con-
trol littermates 24 h after injection (  Fig. 7 A  ), though caspase 3 
is activated in both groups of mice 48 h after DEN injection.   
To determine whether DEN injection induces expression of 
the antiapoptotic protein Bcl-xL, we performed immunoblot 
analysis of liver lysates. We observed a modest induction of 
Bcl-xL at 24 and 48 h after DEN injection, but the levels 
were not diff  erent between   Socs3   h-KO mice compared with 
littermate controls (unpublished data), suggesting that dysreg-
ulated apoptotic pathways did not result in the earlier devel-
opment of HCC in the absence of SOCS3 in our model. 
  It has recently been demonstrated that IL-6 is rapidly re-
leased after DEN injection (  31  ), and we found that serum 
IL-6 levels were dramatically elevated in   Socs3   h-KO mice 
compared with littermates at 24 h after injection (  Fig. 7 B  ). 
Elevated levels of phospho-STAT3 are observed at both 24 
and 48 h after DEN injection in   Socs3   h-KO mice (  Fig. 7 C  ). 
These data support the hypothesis that SOCS3 may prevent 
DEN-induced HCC formation by altering the response to 
IL-6 rather than by inhibiting apoptotic pathways. 
    DISCUSSION   
  Liver regeneration after PH is a unique growth process in 
which the hepatic mass is rapidly restored after surgical re-
moval of two thirds of the liver. The regenerative process af-
ter PH is dependent on the replication of hepatocytes, which 
are completely diff  erentiated and normally quiescent cells, 
and does not rely on the activation of a compartment of liver 
stem cells. Hepatocyte replication does require the involve-
ment of NPCs, the major source of hepatic cytokines and 
growth factors, and the remodeling of extracellular matrix 
(  6, 8, 32  ). A large number of components of the innate immune 
system, including TNF, complement proteins, and the IL-6  –
  STAT3 pathway, participate in the initiation of liver regener-
ation (  6, 8, 33  ). Additionally, studies have shown that growth 
factors such as HGF, members of the EGF family, and stem 
    Table II.        Development of HCC in   Socs3   h-KO and control 
littermates after DEN injection 
Strain Time
3 mo 6 mo 9 mo 12 mo
Control 0/10 0/5 0/6 4/8
  Socs3   h-KO 0/4 0/3 4/6 4/4
12  –  14-d-old pups were injected with a single dose of 5 mg/kg DEN. At the indicated 
times, male mice were killed and livers were examined for tumors. Macroscopic 
HCCs were confi  rmed by hematoxylin and eosin analysis, as described in Materials 
and methods. Tumor development was signifi  cantly different in   Socs3   h-KO mice as 
determined by a log-rank test, with a p-value of 0.0027.
    Figure 7.         Analysis of early response to DEN injection in   Socs3   
h-KO mice versus littermates.   Mice were injected with 100     g DEN per 
gram of body weight, and liver tissues were harvested 24 and 48 h later. 
(A) DEN injection induces caspase 3 activity at 48 h but similarly in   Socs3  
h-KO (hatched bars) and littermate (black bars) mice. (B) Serum IL-6 levels 
are elevated in   Socs3   h-KO versus littermate mice 24 h after DEN injection. 
(C) Enhanced activation of STAT3 after DEN injection in   Socs3   h-KO  mice. 
Data presented are representative of six mice per genotype per time point 
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activation of STAT3 and ERK1/2 after IL-6 or EGF stimu-
lation. These eff  ects can be blocked by inhibitors of the JAK  –
  STAT (AG490) or MEK  –  ERK1/2 (U0126) pathways. Our 
results are consistent with other work demonstrating that 
SOCS3 (as well as other SOCS proteins) can regulate signal-
ing through the EGFR (  47, 48  ). 
  Calvisi et al. reported that the JAK  –  STAT pathway is en-
hanced in human HCC compared with nonneoplastic liver 
and is associated with the down-regulation of various suppres-
sors of this pathway (  17  ). We wondered whether the enhanced 
hepatocyte proliferation in the regenerating liver and the high 
proliferative capacity of   Socs3   KO hepatocytes in culture would 
predispose these mice to liver carcinogenesis. We found that 
tumor development is accelerated in   Socs3   h-KO mice that are 
injected with DEN, a known hepatocarcinogen. These data 
are consistent with the observation that SOCS3 defi  ciency 
promotes cell growth in human HCC by enhancing the JAK  –
  STAT and focal adhesion kinase signaling pathways (  18  ). Our 
microarray analysis of post-PH liver RNA using DAVID and 
the Kyoto Encyclopedia of Genes and Genomes annotation 
identifi  ed both of these pathways as being activated in   Socs3   
h-KO mice. Recently, Ogata et al. reported that   Socs3   hepatic-
defi  cient mice developed a greater number of hepatic tumors 
that were larger than those of control mice when injected with 
DEN for 6 wk or DEN in combination with 6 mo of a cho-
line-defi  cient,   l    –  amino acid diet (  29  ). Ogata et al. concluded 
that in the setting of infl  ammation-induced tumorigenesis, 
STAT3 was activated and induced expression of antiapoptotic 
proteins such as Bcl-2 and Bcl-  xL   (  29  ). Our fi  ndings included 
accelerated HCC development in   Socs3   h-KO mice after a 
single DEN injection (  Table II  ), but we did not observe a dif-
ference in DEN-induced apoptosis 24 or 48 h after DEN in-
jection as measured by caspase 3 activation or Bcl-  xL   expression. 
However we did observe increased release of IL-6 in   Socs3   h-
KO mice and subsequent enhanced phosphorylation of STAT3. 
It is possible that the elevated levels of IL-6 provide a cell pro-
liferative or survival advantage to tumor cells in   Socs3   h-KO 
mice (  35  –  37, 49  ). Regardless of mechanisms, our results and 
those of Ogata et al. demonstrate that SOCS3 defi  ciency in-
creases the risk of HCC development. 
  Despite the fact that individual pathways involving vari-
ous cytokines and growth factors during liver regeneration 
have been described in detail, there is little information re-
garding the mechanisms that coordinate these events and lead 
to a precisely regulated and synchronized growth process. 
Our work demonstrates that, in the regenerating liver, SOCS3 
regulates not only cytokine expression through various path-
ways involving TLR receptors and the IL-6  –  STAT3 pathway 
but also controls the expression of multiple genes involved in 
proliferative pathways that require ERK activation. We sug-
gest that SOCS3 expression at the early stages of liver regen-
eration is an essential element that coordinates the termination 
of the main cytokine response with the activation of growth 
factors that regulate cell-cycle progression. In the absence of 
SOCS3, hepatocytes acquire an enhanced proliferative ca-
pacity, both in vivo and in culture. Thus, hepatic SOCS3 can 
the IL-6 family, which signals through the IL-6R  –  gp130 to 
activate the STAT3 transcription factor. IL-6 is a key mediator 
of the acute-phase response to infl  ammation, and by control-
ling the IL-6  –  STAT3 pathway, SOCS3 functions as a regu-
lator of this response. Previous work from our laboratory 
showed that   Socs3   expression is greatly induced during the fi  rst 
12 h after PH (  9  ). Our interpretation of these results was that 
SOCS3 halts STAT3 activation and terminates the early phase 
of liver regeneration in which cytokines are major partici-
pants, leading to the growth factor  –  regulated progression of 
hepatocytes through the cell cycle and, ultimately, DNA rep-
lication. Thus, SOCS3 could function at the interface between 
cytokine expression and growth factor activity during the re-
generative response. To directly analyze the role of SOCS3 
during liver regeneration after PH, we studied a variety of 
proliferative processes in   Socs3   h-KO mice. The main fi  ndings 
of this work were that (a)   Socs3   h-KO mice show an enhance-
ment of hepatocyte DNA synthesis and mitosis after PH; (b) 
  Socs3   KO hepatocytes are highly proliferative in primary cul-
ture, even in the absence of growth factors; (c) SOCS3 defi  -
ciency enhances multiple pathways related to both cytokine 
activity and cell proliferation; and (d)   Socs3   h-KO mice de-
velop HCC at an accelerated rate. 
  The enhancement of liver regeneration caused by SOCS3 
defi  ciency was an unexpected result. Based on existing data 
on the role of SOCS3 in blocking STAT3 expression, it was 
expected that SOCS3 defi  ciency after PH would lead to an 
enhanced and prolonged acute-phase reaction that might in-
hibit the proliferative response. However, SOCS3 defi  ciency 
led to both an enhancement of the expression of acute-phase 
response genes and the up-regulation of multiple pathways 
related to cell proliferation. These data are consistent with 
reports in other systems showing that SOCS3 has a broader 
role than the control of cytokine activity, which include the 
enhancement of the proliferation of myeloid cells in the he-
matopoietic system (  38  ), islet cell hyperplasia (  42  ), inhibition 
of insulin receptor phosphorylation associated with the meta-
bolic syndrome in the liver (  43, 44  ), and the promotion of 
liver fi  brosis through TGF-     production (  45  ). Sun et al. re-
ported that STAT3 activation was enhanced after PH in   Socs3   
heterozygous (+/    ) mice, but that hepatocytes isolated from 
these mice and exposed to IL-6 in culture showed a decrease 
in cell proliferation because of increased expression of p21 
(  46  ). We suggest that the diff  erence in our results from those 
of Sun et al. may be explained by the use of   Socs3   h-KO mice 
in our experiments. 
  As expected, IL-6 levels after PH were not altered by he-
patocyte   Socs3   defi  ciency because IL-6 is produced by liver 
NPCs, which were not genetically targeted in our mice. The 
data we obtained with hepatocytes isolated from   Socs3   h-KO 
mice and placed in primary culture demonstrate that these 
cells have a high proliferative activity even when maintained 
in medium without growth factors and are highly sensitive to 
EGF stimulation. Similar to the experiments performed in 
regenerating livers, the increased proliferation of cultured he-
patocytes from   Socs3   h-KO mice is associated with enhanced JEM VOL. 205, January 21, 2008 
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  Primary hepatocyte culture, [  3  H]thymidine incorporation, and 
kinase inhibitor treatment.     Primary hepatocytes were isolated from   Socs3   
h-KO mouse and control livers by collagenase perfusion and Percoll gradi-
ents, as previously described (  54  ). To measure DNA replication in cultured 
hepatocytes, [  3  H]thymidine was added to media at a fi  nal concentration of 
1 mCi/ml for 4 h, and incorporation was measured as previously described 
(  55  ). Where indicated in the fi  gures, 20 ng/ml IL-6 or 30 ng/ml EGF was 
added to media. For kinase inhibitor experiments, 50     M AG490, 5     M 
U0126, or DMSO (vehicle control) was added 1 h before IL-6 or EGF 
stimulation. Total RNA and protein lysates were prepared from hepatocyte 
cell cultures as described. 
  Microarray analysis of 18-h PH samples.     To perform statistically rele-
vant gene expression profi  ling at 18 h after PH, additional PHs were per-
formed so that there were 9  –  11 samples for each genotype at this time point. 
Total RNA was isolated as described in Materials and methods and then pu-
rifi  ed using the RNeasy kit (QIAGEN). Equal amounts of each sample were 
pooled, resulting in three groups per genotype. All samples were of good 
quality, as assessed by a bioanalyzer (model 2100; Agilent Technologies). A 
detailed description of microarray methods can be found in Supplemental 
materials and methods. Microarray data have been deposited in the Gene 
Expression Omnibus under accession no.   GSE9549  . 
  TRNA.     Promoter analysis was performed using PAINT (version 3.5, avail-
able at http://www.dbi.tju.edu/dbi/tools/paint) (  27  ). The input fi  le con-
tained the Locuslink identifi  ers for 583 Aff  ymetrix probe sets determined by 
microarray to be up-regulated   >  1.5-fold in   Socs3   h-KO mice 18 h after PH. 
PAINT retrieved 5 kb of 5     fl  anking sequence for 524 genes and identifi  ed 
473 unique promoters. Using a TRE core similarity threshold of 1, 132 
TREs were found for known promoters within the input sequences. 
PAINT tested for enrichment of specifi  c TREs and transformed the results 
into a candidate interaction matrix based on a p-value threshold of 0.05 and 
a false discovery rate threshold of 0.3. For the group of genes analyzed, the 
p-values for signifi  cance of enrichment of each TRE were calculated using 
hypergeometric distribution, with the abundance of each TRE compared 
with the default PAINT reference set of randomly selected   Mus musculus   
promoters. For additional details, please refer to Vadigepalli et al. (  27  ) and 
Addya et al. (  56  ). 
  Statistical analyses.     For all in vivo experiments, three to six mice per gen-
otype per time point were used, except for the microarray analyses done on 
18-h post-PH samples. All in vitro experiments were performed at least 
three times. Data presented are either representative of the replicates, or 
quantitation and statistical analysis of all replicates. Statistical analysis was 
done by nonparametric analysis, using the Mann-Whitney test or an un-
paired   t   test with Welch  ’  s correction. Data are presented as mean   ±   SEM, 
with P   <   0.05 considered statistically signifi  cant. Prism software (GraphPad) 
was used for all statistical analyses except for microarray data. 
  Online supplemental material.    Supplemental materials and methods provides 
detailed methods for the generation and analysis of microarray data (  Fig. 6, 
A and B  ), as performed by the Center for Ecogenetics and Environmental 
Health at the University of Washington. Table S1 provides a complete list of 
the genes and identifi  ers presented in   Fig. 6 A  . Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20070820/DC1. 
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function both as an antiinfl  ammatory agent and a tumor sup-
pressor. SOCS3 may be a suitable target for the regulation of 
acute-phase responses to infl  ammation and for the prevention 
or treatment of HCC. 
  MATERIALS AND METHODS 
  Animals and operative technique.     The generation of mice in which the 
  Socs3   gene has been fl  anked by   loxP   sequences (  Socs3  fl / fl      mice) has been pre-
viously described (  2  ). Hepatocyte-specifi  c excision of the   Socs3   gene was 
achieved by breeding   Socs3  fl / fl      mice with mice expressing the Cre recombi-
nase transgene under control of the albumin promoter (  Alb-Cre  +    ), yielding 
  Socs3   h-KO mice.   Socs3  fl / fl     ,   Alb-Cre                  littermates were used as controls for all 
experiments and are henceforth referred to as littermates. All mice (C57BL/6) 
were free of   Helicobacter   species and were housed in a specifi  c pathogen-free 
facility with 12-h light/dark cycles with free access to standard food and 
water. PH and sham operations were performed as previously described (  n   = 
three to six mice per genotype per time point) (  15, 50  ). Liver remnants were 
weighed after removal of necrotic stumps and sutures and compared with 
postoperative body weight. For HCC experiments, a single i.p. injection of 
5 mg DEN per kilogram (Sigma-Aldrich) was performed 12  –  14 d after 
birth. For short time points, a single injection of 100 mg DEN per kilogram 
(  31  ) was given to 4-wk-old mice. At the times indicated in the fi  gures, mice 
were killed by CO  2   inhalation. All animal studies were performed under ap-
proved institutional animal care and use committee protocols at the Univer-
sity of Washington. 
  Histology.     For all mice harvested 24 h or later after PH, 50     g BrdU per 
gram of body weight was injected i.p. 2 h before harvest. Liver lobes were 
fi  xed and stained as previously described (  15, 22  ). For DEN-induced HCC 
experiments, macroscopic tumors were counted at necropsy. Liver sections 
were stained with hematoxylin and eosin and scored for foci of altered hepa-
tocytes and microscopic HCC using previously described criteria (  51, 52  ). 
  ELISA.     Serum IL-6 concentration was determined using an ELISA, accord-
ing to the manufacturer  ’  s instructions (R  &  D Systems), as described previ-
ously (  15, 22  ). 
  RNA isolation, Northern blotting, and real-time RT-PCR analysis.   
  RNA was isolated from whole liver or primary hepatocytes using TRI  zol   
(Invitrogen) as previously described (  9, 15  ). Northern blot analyses were 
done as previously described (  9, 15  ) using   32  P-labeled cDNA probes for 
  Socs3  ,   Socs1  ,   Cd14  , or   Saa2   (  15  ), or a   32  P-labeled riboprobe for cyclophilin 
(Ambion) as a loading control. Bands were quantifi  ed using a phosphorim-
ager (Storm; Molecular Dynamics). For cDNA synthesis, 2     g RNA from 
18-h PH samples were reverse transcribed using the Retroscript kit (Invitrogen), 
and real-time RT-PCR was performed on the resultant cDNA using FAM-
labeled primers and reagents (Applied Biosystems).         Ct values were cal-
culated by subtracting Ct values for the gene of interest from the Ct values 
for 18S (a housekeeping gene) and then subtracting the     Ct value obtained 
for each gene from nonoperated control mice. Fold change was calculated by 
normalizing all values to those of nonoperated wild-type mice. 
  Immunoblotting and caspase 3 activity assay.     Whole liver or primary 
hepatocyte protein lysates were prepared in a Triton X-100 lysis buff  er and 
quantifi  ed as previously described (  15  ). Caspase 3 activity was determined 
using a fl  uorogenic substrate as previously described (  30  ). 20 or 50     g of 
protein from each sample were separated using SDS-PAGE, and immuno-
blotting was performed using standard procedures with the following pri-
mary antibodies from Cell Signaling Technology (phosphotyrosine 705 STAT3, 
total STAT3, phospho-ERK1/2, phospho-S473  –  Akt, total Akt, phospho-
S/T Akt substrates, phospho-S6 S240/244 protein, phosphotyrosine 701 
STAT1, total STAT1, and phosphotyrosine 649 STAT5), Santa Cruz Bio-
technology, Inc. (cyclin A and p107), Sigma-Aldrich (    -actin), and Zymed 
(total STAT5a/b), and total ERK1/2 (  53  ) as previously described (  9, 22  ). 102 ROLE OF SOCS3 IN LIVER REGENERATION AND HCC | Riehle et al.
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